Sean Pavone / Shutterstock.com

7 January 2025NewsCareersMarisa Woutersen

Troutman Pepper Locke exodus sees teams leave in Chicago and London

Two large teams leave Locke Lord following Troutman Pepper merger | Buchanan opens Chicago office with a large life sciences group | Shoosmiths adds team in London to expand brand-focused IP services.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Paul, Weiss swoops for senior duo from Weil, Gotshal

21 November 2024 The firm brings two life sciences and tech experts to its litigation department | Pair bring combined experience of 45 years from Weil, Gotshal & Manges | Duo offer expertise handling cases for pharmaceutical, biotechnology, and technology clients.

WBD to merge with firm to create ‘powerhouse’ practice

12 September 2024 Deal marks the third major M&A to be announced so far this month | Combined firms have a total gross revenue of more than $742 million | Business marriage seen as “natural fit and clear win-win”.

More on this story

Paul, Weiss swoops for senior duo from Weil, Gotshal

21 November 2024 The firm brings two life sciences and tech experts to its litigation department | Pair bring combined experience of 45 years from Weil, Gotshal & Manges | Duo offer expertise handling cases for pharmaceutical, biotechnology, and technology clients.

WBD to merge with firm to create ‘powerhouse’ practice

12 September 2024 Deal marks the third major M&A to be announced so far this month | Combined firms have a total gross revenue of more than $742 million | Business marriage seen as “natural fit and clear win-win”.

More on this story

Paul, Weiss swoops for senior duo from Weil, Gotshal

21 November 2024 The firm brings two life sciences and tech experts to its litigation department | Pair bring combined experience of 45 years from Weil, Gotshal & Manges | Duo offer expertise handling cases for pharmaceutical, biotechnology, and technology clients.

WBD to merge with firm to create ‘powerhouse’ practice

12 September 2024 Deal marks the third major M&A to be announced so far this month | Combined firms have a total gross revenue of more than $742 million | Business marriage seen as “natural fit and clear win-win”.

More features

UK firm expands in Germany with more litigation hires

Sandoz blocked by UK court from seeking Xarelto profits

The rise of pro-NPE and patent sentiment in the US

UPC sees rising small molecule litigation with Pfizer in the hot seat

Why the Caribbean cannabis economy is ripe for IP protection

China filings push rise in patent applications in Ireland

Brain disorder medtech rivals butt heads at ITC

‘This is not a rescue deal’: How an acquisition fits London firm's plan